Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-24 @ 11:31 PM
NCT ID:
NCT00396656
Eligibility Criteria:
Inclusion Criteria:
* Caucasian; male or female outpatients and age between 40-65 years of age, inclusive.
* At Visit 2 all patients must have a mean sitting diastolic blood pressure (msSBP) of ≥ 90 mmHg and \< 110 mmHg.
Exclusion Criteria:
* If a single reading for arterial hypertension in msSBP \> 180 mmHg or msDBP \> 110 mmHg at any visit after randomization.
* Inability to discontinue all prior antihypertensive medications safely for a period of 2 weeks prior to randomization.
* Known history of hypotensive symptoms or orthostatic hypotension.
* Concomitant use of statins or statin intake during the four weeks prior to Visit 1.
* Known Keith-Wagener grade III or IV hypertensive retinopathy.
* A history of heart failure (NYHA II-IV).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
65 Years
Study:
NCT00396656
Study Brief:
Protocol Section:
NCT00396656